Genomic Landscape of Primary Resistance to Osimertinib Among Hispanic Patients with EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC): Results of an Observational Longitudinal Cohort Study

Overview of attention for article published in Targeted Oncology, April 2023

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#18 of 626)
High Attention Score compared to outputs of the same age (89th percentile)
High Attention Score compared to outputs of the same age and source (86th percentile)

So far, Altmetric has seen 23 X posts from 23 X users, with an upper bound of 49,626 followers.

RT @chamorrodf: Very humbled to share our last publication. We characterized the genomic landscape among NSLC 🫁 patients with primary res…

RT @chamorrodf: Very humbled to share our last publication. We characterized the genomic landscape among NSLC 🫁 patients with primary res…

RT @chamorrodf: Very humbled to share our last publication. We characterized the genomic landscape among NSLC 🫁 patients with primary res…

RT @chamorrodf: Very humbled to share our last publication. We characterized the genomic landscape among NSLC 🫁 patients with primary res…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 19 additional X posts.